Plunging stocks have elevated the level of unrest in global markets, with a 21% plunge in the price of Tesla (TSLA) turning heads. Meanwhile, investors are also contending with AstraZeneca (AZN) putting the brakes on phase three testing of its experimental vaccine after a trial participant became severely ill.
Video Length: 00:01:05




Comments
Log in or sign up to join the conversation.